Lonza NHEM-Neo/NHEM-Ad normal human epidermal melanocytes

Monday, 18 April, 2011 | Supplied by: Lonza Australia Pty Ltd

NHEM-Neo (Neonatal) and NHEM-Ad (Adult) normal human epidermal melanocytes with optimised growth media can be used in a variety of skin-related research including: pigmentation and cosmetics testing; cellular differentiation; antigen expression; melanoma; UV and sun damage studies; and dermal disorders.

Cells undergo stringent QC testing to ensure good growth and performance with outstanding lot-to-lot consistency: purity is assessed via immunofluorescent labelling with most lots at 85% Mel-5; guaranteed 70% conversion of L-dopa to dopa-melanin to confirm functional performance of adult melanocytes; morphology and proliferative evaluations are performed through serial passages after cryopreservation; cells test negative for HIV-1 and hepatitis B and C.

MGM-4 (Melanocyte Growth Medium-4) is recommended for optimal growth and survival in culture. ET-3 Growth Supplement, an additional growth factor required for adult melanocyte growth, is available separately to supplement the MGM-4 BulletKit for a complete formulation specifically designed for growing adult melanocytes.

Online: www.lonza.com
Phone: 03 9550 0883
Related Products

AdipoGen Life Sciences tubulin products for neurodegeneration research

AdipoGen Life Sciences offers a broad range of microtubule research solutions. This includes...

SYnAbs monoclonal antibodies

SYnAbs produces innovative monoclonal antibodies against poor immunogenic compounds and complex...

Merck VirusExpress Lentiviral Production Platform

The platform helps to overcome lentiviral production challenges and can reduce process...

  • All content Copyright © 2020 Westwick-Farrow Pty Ltd